Literature DB >> 28155609

Pathophysiology of Diabetic Dyslipidaemia.

Theodosios Filippatos1, Vasilios Tsimihodimos1, Eleni Pappa1, Moses Elisaf2.   

Abstract

BACKGROUND: Patients with diabetes usually exhibit diabetic dyslipidaemia. AIM: The aim of the review is to present the quantitative and qualitative alterations of lipids and lipoproteins and the associated mechanisms in patients with diabetic dyslipidaemia.
RESULTS: The main quantitative changes observed in patients with diabetic dyslipidaemia are increased triglycerides and decreased high-density lipoprotein (HDL) cholesterol levels. Qualitative abnormalities mainly include increased small dense low-density lipoprotein (LDL) particles (despite similar serum LDL cholesterol levels as non-diabetic subjects) and alterations in the apolipoprotein content of HDL particles. Alterations in the activities of enzymes involved in lipoprotein metabolism, such as cholesteryl ester transfer protein, and the lipoprotein content of lipid particles, along with their glycation and oxidation, play a role in the pathogenesis of diabetic dyslipidaemia.
CONCLUSION: Diabetic dyslipidaemia is associated with quantitative and qualitative alterations of lipids and lipoproteins, which are associated with increased cardiovascular risk. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.org.

Entities:  

Keywords:  Diabetes; apolipoprotein; atherosclerosis; dyslipidaemia; high-density lipoprotein; triglycerides

Mesh:

Substances:

Year:  2017        PMID: 28155609     DOI: 10.2174/1570161115666170201105425

Source DB:  PubMed          Journal:  Curr Vasc Pharmacol        ISSN: 1570-1611            Impact factor:   2.719


  5 in total

1.  Remnant cholesterol for the detection of glucose metabolic states in patients with coronary heart disease angina pectoris.

Authors:  Yang Wang; Yijia Liu; Rongrong Yang; Zhu Li; Jinyu Su; Tong Yang; Mei Ma; Guangwei Pan; Xianliang Wang; Lin Li; Chunquan Yu
Journal:  Acta Diabetol       Date:  2022-07-23       Impact factor: 4.087

Review 2.  Mediterranean Diet and Obesity-related Disorders: What is the Evidence?

Authors:  Giovanna Muscogiuri; Ludovica Verde; Cem Sulu; Niki Katsiki; Maria Hassapidou; Evelyn Frias-Toral; Gabriela Cucalón; Agnieszka Pazderska; Volkan Demirhan Yumuk; Annamaria Colao; Luigi Barrea
Journal:  Curr Obes Rep       Date:  2022-09-30

3.  Crocin ameliorates MicroRNAs-associated ER stress in type 2 diabetes induced by methylglyoxal.

Authors:  Vahid Radmehr; Akram Ahangarpour; Seyyed Ali Mard; Layasadat Khorsandi
Journal:  Iran J Basic Med Sci       Date:  2022-02       Impact factor: 2.532

Review 4.  Nonalcoholic Fatty Pancreas Disease: Role in Metabolic Syndrome, "Prediabetes," Diabetes and Atherosclerosis.

Authors:  T D Filippatos; K Alexakis; V Mavrikaki; D P Mikhailidis
Journal:  Dig Dis Sci       Date:  2021-01-19       Impact factor: 3.199

5.  Effect of SGLT inhibitors on weight and lipid metabolism at 24 weeks of treatment in patients with diabetes mellitus: A systematic review and network meta-analysis.

Authors:  Mao-Bing Chen; Hua Wang; Wei-Yan Cui; Hua-Lan Xu; Qi-Han Zheng
Journal:  Medicine (Baltimore)       Date:  2021-02-12       Impact factor: 1.817

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.